Health
AstraZeneca's COPD Drug Shows Promising Results
AstraZeneca’s drug has shown significant success in reducing dangerous flare-ups for patients with Chronic Obstructive Pulmonary Disease (COPD) in late-stage trials. The results are seen as a major breakthrough for the pharmaceutical company.
Coverage timeline — 1 article
STAT News
STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and more
An AstraZeneca drug reduced the dangerous flare-ups that worsen COPD in a pair of late-stage trials
2026-09-09 13:15 UTC